VBI Vaccines Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.53 | -$0.53 | -$0.53 |
Q2 2024 | 1 | -$0.32 | -$0.32 | -$0.32 |
Q3 2024 | 0 | -$0.22 | -$0.22 | -$0.22 |
Q4 2024 | 0 | -$0.15 | -$0.15 | -$0.15 |
Q1 2025 | 0 | -$0.12 | -$0.12 | -$0.12 |
Q2 2025 | 0 | -$0.09 | -$0.09 | -$0.09 |
Q3 2025 | 0 | -$0.05 | -$0.05 | -$0.05 |
Q4 2025 | 0 | -$0.03 | -$0.03 | -$0.03 |
VBI Vaccines Inc. Earnings Date And Information
VBI Vaccines Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-2.17 earnings per share for the quarter, missing analysts' consensus estimates of $-0.32 by $1.85. The company had revenue of 1.21 M for the quarter and had revenue of 8.68 M for the year. VBI Vaccines Inc. has generated $-6 earnings per share over the last year ($-5.96 diluted earnings per share) and currently has a price-to-earnings ratio of -0.02. VBI Vaccines Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based on prior year's report dates.
VBI Vaccines Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
05/15/2024 | Q1 2024 | -$0.53 | -$0.73 | -0.2 | $2.85 M | $1.21 M |
04/16/2024 | Q4 2023 | -$0.00 | $5.36 M | $853,000 | ||
11/14/2023 | Q3 2023 | -$0.14 | -$0.97 | -0.83 | $6.62 M | |
08/14/2023 | Q2 2023 | -$2.16 | -$5.18 | -3.02 | $720,000 | |
05/15/2023 | Q1 2023 | -$2.27 | -$4.34 | -2.07 | $817,000 | $485,000 |
03/13/2023 | Q4 2022 | -$2.10 | -$2.28 | -0.18 | $1.98 M | $293,000 |
11/10/2022 | Q3 2022 | -$2.40 | -$3.26 | -0.86 | $317,000 | |
08/08/2022 | Q2 2022 | -$2.10 | -$7.85 | -5.75 | $346,000 | |
05/09/2022 | Q1 2022 | -$2.40 | -$2.98 | -0.58 | $126,000 | |
03/07/2022 | Q4 2021 | -$2.10 | -$2.19 | -0.09 | $81,000 | |
11/08/2021 | Q3 2021 | -$2.40 | -$1.85 | 0.55 | $203,667 | $107,000 |
08/02/2021 | Q2 2021 | -$2.40 | -$2.05 | 0.35 | $481,333 | $142,000 |
05/10/2021 | Q1 2021 | -$2.10 | -$2.11 | -0.01 | $301,000 | |
03/02/2021 | Q4 2020 | -$1.80 | -$1.90 | -0.1 | $164,000 | |
11/02/2020 | Q3 2020 | -$1.50 | -$1.66 | -0.16 | $328,250 | $298,000 |
07/31/2020 | Q2 2020 | -$1.50 | -$1.32 | 0.18 | $631,250 | $184,000 |
05/06/2020 | Q1 2020 | -$2.10 | -$1.41 | 0.69 | $415,000 | |
03/05/2020 | Q4 2019 | -$1.80 | -$1.82 | -0.02 | $574,000 | |
11/06/2019 | Q3 2019 | -$3.60 | -$4.59 | -0.99 | $702,667 | $647,000 |
08/09/2019 | Q2 2019 | -$4.20 | -$4.04 | 0.16 | $489,000 | $640,000 |
VBI Vaccines Inc. Earnings: Frequently Asked Questions
-
When is VBI Vaccines Inc.'s earnings date?
VBI Vaccines Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates.
-
How can I listen to VBI Vaccines Inc.'s earnings conference call?
The conference call for VBI Vaccines Inc.'s latest earnings report can be listened to online.
-
How can I read VBI Vaccines Inc.'s conference call transcript?
The conference call transcript for VBI Vaccines Inc.'s latest earnings report can be read online.
-
How much revenue does VBI Vaccines Inc. generate each year?
VBI Vaccines Inc. (:VBIV) has a recorded annual revenue of $8.68 M.
-
How much profit does VBI Vaccines Inc. generate each year?
VBI Vaccines Inc. (:VBIV) has a recorded net income of $8.68 M. VBI Vaccines Inc. has generated $-5.96 earnings per share over the last four quarters.
-
What is VBI Vaccines Inc.'s price-to-earnings ratio?
VBI Vaccines Inc. (:VBIV) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.